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Objectives: To assess the early experience with the transfemorally placed modular endovascular MinTec graft (TPEG) 
for abdominal ortic aneurysm (AAA). 
Design: One single centre prospective evaluation of the endograft procedure as well as early postoperative r sults. 
Setting: An academic teaching hospital. 
Patients: 30 consecutive patients treated uring a period of 15 months. 
Results: Peri- and postoperative morbidity and mortality were evaluated according to the recommendations of the Ad 
Hoc Committee on Reporting Standards. The endograft procedure was successful in 28 patients (93.4%); two.patients 
(6.6%) needed conversion into open conventional y-graft replacement; one patient died 36 days following intervention 
from multiple organ failure. Another patient died from pancreatitis unrelated to the implantation. Endoleaks were treated 
by "overstenting" or distal extension of the endografts, but conversions were unnecessary. Five severe adverse vents 
were noted in four patients. 
Co'nclusions: TPEG is a feasible but technically demanding procedure, requiring both surgical techniques and catheter 
skills. The potential for less operative morbidity and simpler aneurysm management compared to conventional open 
surgery may be present. Close follow-up of patients is necessary tounderstand the development and treatment of endoleaks. 
Key Words: Transfemorally placed endografts; Abdominal aortic aneurysm; Endovascular procedure; Stent-grafts. 
Introduction 
Since repair of abdominal aortic aneurysm (AAA) was 
first described, 1 surgical graft replacement rather than 
simple aneurysm observation has evolved over the 
last four decades. 2 
Perioperative complication rates as high as 5-10% 
and mortality rates of between 3-5% and 10-14% are 
reported. 3-5 
The risk of active surgical intervention has to be 
weighed against the risk of rupture, against a back- 
ground of limited life expectancy and a variety of 
comorbid conditions. With the introduction of endo- 
luminal aneurysm management, a more aggressive 
approach towards repair might be warranted and will 
probably influence future treatment policies. 
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For the endovascular study group, Vienna. 
In contrast o other publications 6'7 this report doc- 
uments a single centre xperience with a modular thin- 
walled polyester graft, mounted on a self-expanding 
Nitinol stent. The time frame of 15 months was chosen 
because the device used was available only for a 
limited interval and was subsequently withdrawn 
from the market. 
Patients and Methods 
From March 1995 to the end of May 1996, a consecutive 
series of 30 patients underwent transfemorally placed 
endovascular grafts (TPEGs) for infrarenal abdominal 
aortic aneurysm (AAA). 
The endograft used (Mialhe-Stentor®, MinTec Inc., 
Freeport, Grand Bahama; distributed in Austria by 
CrossTec, Vienna) is a self-expanding, modular, multi- 
segmental endoprosthesis, based upon a Nitinol 
framework in a tubular zig-zag configuration. The 
stent frame is covered by a woven, medium-per- 
meability 0.1 mm polyester fabric cover. The implants 
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are available in a straight (tube) and bifurcated con- 
figuration. The y-graft consists of two components, 
which are introduced sequentially and assembled 
intraluminally. 
At the trailing part of the main aortic section there 
is a short branch of 10 mm diameter, situated contra- 
laterally to the vascular access site, into which the 
second extension graft limb is inserted. The devices 
are available in lengths ranging from 143 to 163 mm 
and diameters of 20-26 mm. The extension grafts vary 
in diameter between 10 and 12 mm and are available 
in different lengths ranging from 60 to 100 ram. The 
tubular aortic graft is available in diameters ranging 
from 20 to 26 mm and in lengths from 80 to 100 ram. 
The data were collected prospectively and no en- 
dografts were implanted prior to the study. All patients 
were aware of the experimental nature of the pro- 
cedure, and gave informed consent o participate in 
the study, which had been approved by the local ethics 
committee. 8 
Each implant had to be tailored individually and 
therefore only patients awaiting elective procedures 
were eligible. All patients presented with aneurysms 
that by current practice standards required repair. A 
spiral computed tomography (CT) scan and intra- 
arterial arteriography with a calibrated catheter were 
performed to size the aneurysm accurately. 
The median age of the 28 men and two women 
was 70.0 years (range: 54.6-79.6 years). All patients 
receiving a stent-graft are numbered in consecutive 
order, which is referred to throughout the article. No 
patients were excluded from this series (Table 1). 
Patients showed the typical comorbidities in peri- 
pheral arterial disease (46.6% current smokers; 10% 
diabetic metabolic state; 30% hyperlipidemic state; 
66.6% arterial hypertension (RR>160/90mmHg); 
46.6% coronary artery disease; 56.6% chronic ob- 
structive pulmonary disease; 29.2% cerebrovascular 
disease; and note that in various patients more than 
one risk factor was present, Table 1). According to the 
ASA classification, 43.3% were in stage III and 56.7% 
in stage IV, respectively (Table 1). Aneurysms were 
graded into four categories, with respect o their in- 
volvement of the iliac and hypogastric arteries (Table 
2). Type "A" were aneurysms involving only the in- 
frarenal aorta, presenting with a distinct distal cuff. 
Type "B" were aneurysms of the infrarenal aorta with 
involvement of the aortic bifurcation. Type "C" were 
aneurysms of the infrarenal aorta including en- 
largement of the proximal part of the common iliac 
arteries. Type "D" were aneurysms similar to type "C", 
but with additional involvement of the hypogastric 
arteries. 
In accordance with other groups we adhere to the 
so-called "TEAM" approach, 6 where surgeons, inter- 
ventional radiologists and angiologists work together 
in the operating suite. 
All procedures were performed in the operating 
theatre using general anaesthesia nd endotracheal 
intubation. The vascular surgical operating suite is 
equipped with an image intensifier and a radiolucent 
operating table. The patients were prepared and 
draped for a conventional "open" surgical procedure 
in the event of a failing endoluminal repair and sub- 
sequent conversion. 
After gaining access to the femoral artery by direct 
exposure, on-table angiography was obtained to 
identify and mark the renal arteries and the aortic 
bifurcation. Systemic heparin was administered 
100 IU/kg body weight, with exception of patient 15. 
Fluoroscopic guidance was used to introduce the 
endograft into the aorta employing an 18F delivery 
sheath. The large-bore diameter necessitates a femoral 
cut-down at one side, whereas a percutaneous access 
in the contralateral side is feasible when a bifurcated 
graft is implanted. 
The principles of vascular access, implant in- 
troduction, deployment and anchoring as well as com- 
pletion of the procedure have been described by 
several investigators and seem to follow a common 
principle, but vary to some extent depending upon 
the specific implant used.  6;'9-12 
After completion of the procedure an on-table an- 
giogram was routinely performed. Prior to discharge, 
at 3 months, 6 months, 1 year and then biannually, a
CT scan with contrast and an IV-angiography was 
obtained. In addition, patients were scheduled for a 
clinical examination as an outpatient whenever 
needed. 
Results 
The mean diameter of the treated AAA was 5.7cm 
(range: 4.5-8.0 cm). The average operative time was 
234 rain (range: 115-340 min), which seems similar to 
elective conventional open surgery. 13 During the first 
year of the study 22 patients underwent elective con- 
ventional open surgery for AAA, for which the average 
operating time was 243 rain. Fluoroscopy time was 
41.6 min (range: 11-98.4 min) and 235 ml (range: 
110-400 ml) of contrast were used (Table 2). The Sten- 
tor-System allowed the implantation of endografts in 
the straight (n=12) as well as the bifurcated con- 
figuration (n=18). Tube graft implantations were 
shorter and needed less fluoroscopy time and less 
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Table 2. Technical data of the 30 procedures in 30 patients undergoing endovascular aneurysm management. 
Patient Graft AAA-DM Prox neck IMA RII LII AAA Blood Anatomic difficulties OR-time Fluoroscopy Contrast 
(sac)-cm (mm) type replacement (min) (min) (ml) 
1 Bif-Y 4.9 50 O P P C 0-0-0 210 35.1 250 
2 Tube 5.6 30 O P P A 0-0-0 140 29.4 250 
3 Tube 5.7 10 O P P B 0-0-0 Inf lammatory 200 36.0 110 
aneurysm 
4 Bif-Y 5.6 30 O P P B 0-0~0 240 42.0 220 
5 Bif-Y 7.2 17 P P P B 0-0-0 255 38.0 250 
6 Tube 4.5 30 O P P A 0-0-0 230 28.0 160 
7 Tube 4.5 15 O P P A 1-0-0 205 24.0 200 
8 Tube 5.0 18 O P P A 0-0-0 150 28.4 250 
9 Tube 4.9 44 P P P A 0-0-0 Accessory renal artery 105 17.3 110 
10 Bif-Y 5.1 45 O P P C 0-0-0 195 33.0 260 
11 Tube 4.9 20 P P P A 0-0-0 125 17.0 200 
12 Tube 4.9 49 P P P A 0-0-0 Accessory renal artery 120 20.6 120 
13 Tube 4.8 30 P P P A 1-0-0 Horseshoe kidney 210 29.0 180 
14 Bif-Y 4.9 20 P P P B 0-0-0 240 62.0 240 
15 Bif-Y 5.2 12 O P P C 1-0-2 257 43.0 400 
16 Bif-Y 6.0 20 O P P B 0-0-2 245 48.0 250 
17 Bif-Y 6.2 28 O P P B 0-0-0 190 62.0 150 
18 Bif-Y 8.0 50 O P P B 0-0-0 240 67.0 155 
19 Bif-Y 4.8 40 O P O D 2-2-1 Inf lammatory 245 45.0 340 
aneurysm 
20 Bif-Y 6.5 18 O O O D 0-0-0 Accessory renal artery 340 55.4 340 
21 Tube 5.0 45 O P P A 0-0-0 186 11.0 135 
22 Bif-Y 6.6 15 O P P B 0-0-0 240 59.4 200 
23* B i f -Y  6.9 18 O P P B n.a. 620 98.4 320 
24 Bif-Y 6.5 25 O P /A  P C 0-0-2 Accessory renal artery 240 49.4 290 
25 Bif-Y 6.0 50 P P P B 0-0-0 125 23.5 200 
26 Bif-Y 6.5 27 O P P B 0-0-0 Accessory renal artery 225 54.9 400 
27 Bif~Y 5.5 62 P P P D 0-0-0 250 88.4 400 
28* Bif-Y 5.7 22 O P P B n.a. 780 88.0 400 
29 Tube 5.5 28 P P P A 0-0-0 125 14.5 120 
30 Tube 7.6 35 O P P A 0-0-0 115 12.0 125 
(*) in patients marked the procedure was converted to open repair, 
Graft: Tube = tubular graft; Bif-Y = bifurcated y-graft. 
AAA types A-D,  see "Methods" section. 
IMA = inferior mesenteric artery; RII = right internal iliac artery; LII = left internal iliac artery; O ~ occluded; P = patent; A = aneurysmal.  
Blood replacement: OR-ICU-surgical ward; n.a. =not  applicable. 
contrast (159min; 22.3min; 163ml) than y-grafts 
(233 rain; 50.3 min; 271 ml), the difference being stat- 
istically significant at the 0.005 level. Fig. 1 shows an 
artist's impression of the implantation of a tube graft, 
and Fig. 2 shows diagrammatically the implantation 
of a bifurcated graft. The need to catheterise the main 
trunk of the graft via the orifice of the contralateral 
graft limb to assemble the extension graft is clearly 
demonstrated. 
ASA classification and clearance for surgery 
ASA classification was routinely employed in all 
patients prior to surgery to assess the risk for an- 
aesthesia. ~4The distribution of patients in the re- 
spective ASA classification is given in Table 1. At the 
beginning of our experience all patients undergoing 
TPEG had to be considered fit enough to undergo 
an open procedure as well. After the positive initial 
experience patients who were borderline for an open 
procedure (patients 15, 18, 20 and 23) were accepted 
as candidates for the endovascular operation (Table 
1). 
Complex aneurysms 
Patients 3 and 19 presented with inflammatory an- 
eurysms, proven by CT scan in both cases. In addition, 
ureter obstruction due to the inflammatory aneurysm 
was present in patient 3 (Fig. 1). Patient 13 presented 
with a horseshoe kidney with accessory renal arteries 
deriving from the aneurysm body. Five additional 
patients presented with accessory renal arteries 
(patients 9, 12, 20, 24 and 26) either adjacent to the 
aneurysm or originating from the aneurysm body 
(Table 2). 
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Fig. 1. Implantation of a straight ube graft. Note the thick wall of 
the aneurysm sac, as seen in inflammatory aneurysms. A catheter 
is placed in the obstructed left ureter (patient 3). 
intensive care stay 
Every patient but one was admitted postoperatively 
to an ICU according to the ethics committee's re- 
commendation for at least 12 h. The average admission 
time to the ICU was 21 h in patients with a successful 
TPEG procedure. 
Mortality 
The 30-day mortality was zero. However, patient 28 
died in the same hospital stay after an ICU stay of 
36 days, due to multiorgan failure and sepsis (see 
"Conversions"). Patient 19 died 188 days after suc- 
cessful implantation due to necrotising pancreatitis 
which was unrelated to the aneurysm management. 
The diagnosis was confirmed by post-mortem ex- 
amination in both cases. 
Fig. 2. Diagrammatic view of a bifurcated endograft during im- 
plantation. Note the proximal uncovered end of the device. The 
bifurcated graft needs catheterisation f the contralateral graft limb 
in order to deploy the extension graft as shown in the figure. 
Conversions 
In two patients the endovascular procedure had to be 
converted to open surgery. In patient 23 a bifurcated 
endograft was intended, but misplacement of the 
contralateral guide wire remained undetected until the 
extension graft was deployed. Endoluminal retrieval of 
the extension graft was thought o be impossible and 
the endograft was removed and an aortobifemoral y-
graft implanted using conventional surgical tech- 
niques. Postoperatively, the patient developed multi- 
organ failure requiring circulatory, renal, and 
ventilatory support. After 38 days in the ICU and 68 
days in hospital the patient was discharged in stable 
condition. 
In patient 28, during the introduction and ad- 
vancement of the main body of the endograft, in- 
cidental dissection of the iliac artery and the distal 
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infrarenal aorta occurred. Partial re-entry of the device 
into the aortic lumen obscured the problem and the 
graft was fully assembled intramurally. Immediately 
after completion of the procedure, blockage of the 
endograft occurred. The diagnosis was confirmed 
through on-table angiography. Conventional repair 
using a bifurcated graft was performed, but the patient 
subsequently developed multiorgan failure and died 
of sepsis on the 36th postoperative day. The patient 
was on immunosuppression for a previous cardiac 
transplant. In both instances the rescue procedures 
were difficult to carry out, the overall combined op- 
erating time being 10 and 13 h, respectively (Table 2). 
Extragraft low 
After insertion of the endografts, nine primary 
endoleaks were observed after successful graft de- 
ployment (32.1%). Extragraft flow was defined ac- 
cording to White. 1~ The same procedure was used to 
manage four leaks successfully either by placing an 
additional aortic stent-graft (n =1; patient 2; "over- 
stenting') or a distal iliac artery extension graft (n = 
1; patient 24), or by iliac artery banding (n = 2; patients 
20 and 27). Thus, in 82.1% (23/28) of the implantations 
the AAA was excluded. In the remaining five patients 
the leak was not detected (n =2; patients 12 and 13) 
or was considered minimal (n =3; patients 4, 5 and 
16). Of the leaks, eight originated from the distal 
anastomoses (patients 2, 4, 12, 13, 16, 20, 24 and 27); 
whereas one was a proximal endoleak (patient 5). 
Secondary endoleaks have not been detected so far. 
Incidental coverage of renal arteries 
In three patients (patients 15, 22 and 30), the proximal 
uncovered part of the stent-graft was incidentally 
placed over one renal artery orifice. This caused an 
infarction of the lower pole in patient 15. The renal 
arteries remained patent in all three patients during 
the follow-up of 6, 4 and 4.4 months respectively. No 
deterioration of renal function was noted in all these 
patients. 
Intentional coverage ofrenal arteries 
In three patients (patients 12, 13 and 24) accessory 
renal arteries were occluded intentionally by the 
covered part of the graft. No patient experienced a 
clinically relevant deterioration ofthe kidney function. 
Two patients experienced silent kidney infarctions dur- 
ing follow-up (patients 12 and 13). 
Transfusion requirements 
Patients 7 and 13 needed blood transfusions due to 
problems with haemostatic valves, patient 15 was 
implanted on active oral anticoagulant treatment, and 
patient 19 required local lysis and evacuation ofa groin' 
haematoma (see below). The two patients undergoing 
conversion procedures needed 6and 10 units of blood 
respectively (patients 23 and 28). Therefore, 23 im- 
plantations were done without any blood replacement. 
The need for transfusion is shown in Table 2. 
Reocclusions 
One graft limb occluded immediately following the 
procedure (patient 19). Local lysis of the graft via the 
left transbrachial route was successful, but a haem- 
atoma from the groin adjacent to the vascular access 
site had to be evacuated. After 3 months, the graft 
reoccluded and was again reopened by means of local 
lysis. One month later the left graft limb blocked again, 
leaving the patient with intermittent claudication until 
he died. 
Bowel obstruction 
On postoperative day 6, one patient (patient 20) de- 
veloped bowel obstruction due to paralytic ileus, and 
intestinal ischaemia was strongly suspected due to the 
complicated abdominal history (Table 1). Exploration 
was felt to be indicated, but was negative. 
Postimplantation syndrome 
Pyrexia of unknown origin (up to 39 °C) developed in 
seven patients (patients 4, 6, 8, 10, 11, 14 and 21) which 
resolved spontaneously. Cultures taken at the time of 
implantation and during the immediate postoperative 
follow-up remained negative. Patients 1, 2 and 4 com- 
plained of back pain, which resolved spontaneously 
within the first postoperative week following treat- 
ment. 
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Complications at the access sites 
At the femoral cut-down,  two plaque ruptures were 
observed ur ing the graft advancement  (patients 7 and 
12). After wi thdrawal  of the sheath, local thromboend-  
arterectomy and vein patch closure were performed. 
Fol lowing p lacement of bifurcated endografts,  one 
local haematoma was treated conservatively (patient 
27) and one pseudoaneurysm was successfully man-  
aged by u l t rasound-gu ided compress ion (patient 24). 
The adverse events are given according to the re- 
commendat ions  of the ad hoc Committee on report ing 
standards for lower extremity ischaemia 16 and are 
summar ised in Table 3. Five severe adverse events 
have been recorded in four patients. 
Hospital stay 
After exclusion of the two patients (patients 23 and 
28) who  had an adverse course fol lowing open surgery, 
the postoperat ive length of stay in the 28 successful 
patients was a median of 6 days (range: 4-11 days). 
Follow-up 
Three patients have completed their 18-month fol low- 
up, seven their 12-month and four their 6-month check- 
up; the remaining 16 patients have been observed for 
intervals of less than 6 months. All the endografts  
remained patent, with one exception (patient 19). The 
median postoperat ive fol low-up is 7.6 months.  No  
graft migrations, pseudoaneurysms,  secondary leaks 
or embolic episodes have been detected. Dur ing fol- 
low-up, patient 1 developed unstable angina and 
underwent  aortocoronary bypass graft ing 11 months  
after endograff ing. In patient 9, a non-Hodgk in  lym- 
phoma was d iagnosed 11 months  postoperat ively and 
the patient has currently completed the first cycle of 
chemotherapy.  In patient 26, a pu lmonary  lesion was 
detected 3 months  postoperatively, but  the patient 
refused further investigation. 
Discussion 
Open surgical repair is the standard treatment for 
AAA,  but carries a mortal i ty risk of between 1.~ 
and 6.5%. 3-5 As in other areas of surgery, the tendency 
towards less invasive techniques is inevitable. Ad-  
vancement  of an endograft  f rom the groin into the 
Table 3. Adverse events following TPEG observed in 30 patients.* 
Number of events 
Adverse events A B C 
mild moderate severe 
Systemic/remote 
Respiratory 
failure 
Renal 0 
insufficiency 
Sepsis 0 
Multiple organ 0 
failure 
Pyrexia of 1 
unknown 
origin 
Back pain 0 
Local/vascular 
Leak; graft/ 4 
vessel 
Damage access 0 
artery 
Damage 1 
contralat, artery 
Graft 0 1 
thrombosis 
Blood 0 7 
transfusion 
2 0 A = transient, ot 
requiring ventiiator; 
B = transient, requiring 
ventilator; 
C = permanent/death 
2 0 A = transient; 
B = transient, requiring 
dialysis; 
C =permanent, fatal 
0 1 A = requiring drug 
therapy; 
B = requiring 
resuscitation; 
C = fatal 
1 1 A = requiring drug 
therapy; 
B = requiring 
resuscitation; 
C = fatal 
7 0 A = resolved without 
treatment; 
B = drug therapy 
required; 
C = operation required, 
fatal 
3 0 A = resolved without 
treatment; 
B = drug therapy 
required; 
C = fatal 
2 A = observed, no 
therapy; 
B = required 
intervention, stenting; 
C = re-do operation, 
conversion 
0 A = observed no 
treatment; 
B = local treatment 
required; 
C = required extensive 
repair 
0 A = observed no 
treatment; 
B = local treatment 
required; 
C = extensive vascular 
repair 
0 A = not corrected; 
B = required re-do; 
local lysis; 
C = limb loss 
0 A = no transfusion 
given; 
B =blood transfusion 
required; 
C = fatal 
Local/non-vascular 
Haematoma 0 0 1 A = observed, resolved; 
B = aspirated; 
C = surgical drainage 
* Summarised according to R. Rutherford ~6. 
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infrarenal aorta is a less invasive endoluminal option, 
which might have an impact in improving the safety 
of AAA repair. The current echnology was pioneered 
by J. Parodi and his colleagues and the first clinical 
cases were reported in 1991.1°'11'17'18 Bifurcated grafts 
can now be deployed either through a "pull-over" 
manoeuvre 9'12'19 or can be assembled within the 
aneurysm sac, but common to all variations is the 
concept of thin-walled grafts connected to stents. 2° 
In our country patients who undergo open an- 
eurysm surgery require an average postoperative 
hospital stay of 12-14 days, or even longer in 
complicated cases. TPEG seems to necessitate a much 
shorter length of stay, which seems to render the 
endograft procedure cost-effective, despite the ex- 
pense for the procedure. 13
The endograft procedure is potentially safe and 
simple. Complications requiring open conversion 
make subsequent surgery difficult 21 and time-con- 
suming, requiring extensive blood replacement. The 
blood loss may be related to the heparin ad- 
ministration. In addition, the large amounts of con- 
trast administered may contribute to acute renal 
impairment. 21The combination of blood loss, renal 
failure, circulatory instability and the prolonged 
procedure results in a high mortality being reported 
in these patients. 21 
A major problem associated with endograft repair 
of aneurysms i ineffective xclusion of the aneurysm 
sac. ~5 The reasons for this might be incomplete 
attachment between the graft at the proximal or 
distal end and the aortic wall. Defects in the endograft 
itself or at the connection sites between the different 
components may result in an endoleak. This may 
or may not be detected by on;table arteriography 
because the graft materials are thin and very porous, 
and therefore it takes time to seal. Extragraft flow 
present at the end of the procedure may disappear 
within several days. Persistent extragraft flow within 
the aneurysm sac following the procedure has to be 
considered a primary failure. It seems important o 
distinguish minor endoleaks, which will thrombose 
spontaneously, and major ones, which will generate 
continuous pulsatile pressure within the aneurysm 
sac, causing further growth of the aneurysm, 22finally 
leading to rupture. Such leaks require treatment. It
is not known whether thrombosed leaks remained 
sealed or have the potential to reoccur. 23 
Secondary endoleaks have not been observed, but 
the series is small with short follow-up. 
To anchor an endograft securely, a proximal neck 
of at least 1.5 cm is required. Placing the proximal 
end of the stent over the origin of the renal arteries 
would increase the length of proximal attachment 
site, 24 but more experience is required. 
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